Founded:

Ferring was first founded in Sweden in 1950 by Dr. Frederik Paulsen

Headquarters:    

Saint-Prex, Switzerland

International:

Ferring International Center (Switzerland)

Production sites in nine countries (Argentina, China, Czech Republic, Denmark, Germany, Israel, Mexico, Scotland and Switzerland). Two more facilities are being built in the US and India.

Six R&D Centres (in China, Denmark, India, Israel, USA)

Market presence:

In more than 50 countries

Workforce:    

More than 4500 employees worldwide

2010 sales:

EUR 1 Billion

Growth:

Double-digit average annual growth rate over the last two decades

Urology:

MINIRIN® (desmopressin)* is the treatment of choice for bedwetting in children and nocturia in adults.

FIRMAGON® (degarelix)* is a treatment for advanced hormone-dependent prostate cancer.

TESTIM® (testosterone)** is an efficacious and convenient treatment for men suffering from low testosterone.

Reproductive Health:

MENOPUR® (Menotropin)* (REPRONEX® in the US) and BRAVELLE®* (hFSH) are ovarian-stimulating treatments used in preparation for in-vitro fertilisation (IVF).

TRACTOCILE® (Atosiban)* is used to treat pre-term (premature) labour.

Endocrinology:

ZOMACTON® (Somatropin)* is a recombinant human growth hormone used to treat growth failure in children.

Gastroenterology:

PENTASA® (mesalazine)* is used for the treatment of inflammatory bowel diseases.

PICOPREP®* to prepare the colon for endoscopy, surgery or radiology.

GLYPRESSIN® (terlipressin)* for Bleeding Oesophageal Varices and (in some markets) for Hepatorenal syndrome.